DiMartino Rose has filed 7 insider transactions across 5 companies since July 2024.
Most recent transaction: a transaction of 364 shares of ABRDN JAPAN EQUITY FUND, INC. ($JEQ) on October 10, 2025.
Activity breakdown: 5 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 10, 2025 | ABRDN JAPAN EQUITY FUND, INC. | $JEQ | DiMartino Rose | Director | J | Common Stock | 364 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 3, 2025 | ABRDN JAPAN EQUITY FUND, INC. | $JEQ | DiMartino Rose | Director | D | Common Stock | 636 | $8.04 | 364.0000 | 0 | 63.60% | 0.00% |
| Oct. 2, 2024 | ABRDN JAPAN EQUITY FUND, INC. | $JEQ | DiMartino Rose | Director | P | Common Stock | 1000 | $6.19 | 1,000.0000 | 0 | 9999.99% | 0.00% |
| July 16, 2024 | abrdn Healthcare Opportunities Fund | $THQ | DiMartino Rose | Director | P | Common Stock | 1000 | $21.30 | 1,000.0000 | 0 | 9999.99% | 0.00% |
| July 16, 2024 | abrdn World Healthcare Fund | $THW | DiMartino Rose | Director | P | Common Stock | 1000 | $13.31 | 1,000.0000 | 0 | 9999.99% | 0.00% |
| July 16, 2024 | abrdn Life Sciences Investors | $HQL | DiMartino Rose | Director | P | Common Stock | 1000 | $15.53 | 1,000.0000 | 0 | 9999.99% | 0.00% |
| July 16, 2024 | abrdn Healthcare Investors | $HQH | DiMartino Rose | Director | P | Common Stock | 1000 | $18.88 | 1,000.0000 | 0 | 9999.99% | 0.00% |